PKM and carcinoma: A previous investigation revealed that EVs derived from human hepatocellular carcinoma carrying glycolytic enzyme pyruvate kinase M2 isoform (PKM2) foster the progression of carcinoma by promoting PKM2 polarization of macrophages and reconfiguring the tumor immune microenvironment (46).